Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases

Nicholas G. Reich, Justin T Lessler, Jay K. Varma, Neil M. Vora

Research output: Contribution to journalArticle

Abstract

During outbreaks of deadly emerging pathogens (e.g., Ebola, MERS-CoV) and bioterror threats (e.g., smallpox), actively monitoring potentially infected individuals aims to limit disease transmission and morbidity. Guidance issued by CDC on active monitoring was a cornerstone of its response to the West Africa Ebola outbreak. There are limited data on how to balance the costs and performance of this important public health activity. We present a framework that estimates the risks and costs of specific durations of active monitoring for pathogens of significant public health concern. We analyze data from New York City's Ebola active monitoring program over a 16-month period in 2014-2016. For monitored individuals, we identified unique durations of active monitoring that minimize expected costs for those at "low (but not zero) risk" and "some or high risk": 21 and 31 days, respectively. Extending our analysis to smallpox and MERS-CoV, we found that the optimal length of active monitoring relative to the median incubation period was reduced compared to Ebola due to less variable incubation periods. Active monitoring can save lives but is expensive. Resources can be most effectively allocated by using exposure-risk categories to modify the duration or intensity of active monitoring.

Original languageEnglish (US)
Article number1093
JournalScientific Reports
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

Communicable Diseases
Costs and Cost Analysis
Smallpox
Disease Outbreaks
Public Health
Western Africa
Centers for Disease Control and Prevention (U.S.)
Morbidity
Middle East Respiratory Syndrome Coronavirus

ASJC Scopus subject areas

  • General

Cite this

Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases. / Reich, Nicholas G.; Lessler, Justin T; Varma, Jay K.; Vora, Neil M.

In: Scientific Reports, Vol. 8, No. 1, 1093, 01.12.2018.

Research output: Contribution to journalArticle

Reich, Nicholas G. ; Lessler, Justin T ; Varma, Jay K. ; Vora, Neil M. / Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases. In: Scientific Reports. 2018 ; Vol. 8, No. 1.
@article{85c3ce3fdff44190897ade6eaa3172fe,
title = "Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases",
abstract = "During outbreaks of deadly emerging pathogens (e.g., Ebola, MERS-CoV) and bioterror threats (e.g., smallpox), actively monitoring potentially infected individuals aims to limit disease transmission and morbidity. Guidance issued by CDC on active monitoring was a cornerstone of its response to the West Africa Ebola outbreak. There are limited data on how to balance the costs and performance of this important public health activity. We present a framework that estimates the risks and costs of specific durations of active monitoring for pathogens of significant public health concern. We analyze data from New York City's Ebola active monitoring program over a 16-month period in 2014-2016. For monitored individuals, we identified unique durations of active monitoring that minimize expected costs for those at {"}low (but not zero) risk{"} and {"}some or high risk{"}: 21 and 31 days, respectively. Extending our analysis to smallpox and MERS-CoV, we found that the optimal length of active monitoring relative to the median incubation period was reduced compared to Ebola due to less variable incubation periods. Active monitoring can save lives but is expensive. Resources can be most effectively allocated by using exposure-risk categories to modify the duration or intensity of active monitoring.",
author = "Reich, {Nicholas G.} and Lessler, {Justin T} and Varma, {Jay K.} and Vora, {Neil M.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-19406-x",
language = "English (US)",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases

AU - Reich, Nicholas G.

AU - Lessler, Justin T

AU - Varma, Jay K.

AU - Vora, Neil M.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - During outbreaks of deadly emerging pathogens (e.g., Ebola, MERS-CoV) and bioterror threats (e.g., smallpox), actively monitoring potentially infected individuals aims to limit disease transmission and morbidity. Guidance issued by CDC on active monitoring was a cornerstone of its response to the West Africa Ebola outbreak. There are limited data on how to balance the costs and performance of this important public health activity. We present a framework that estimates the risks and costs of specific durations of active monitoring for pathogens of significant public health concern. We analyze data from New York City's Ebola active monitoring program over a 16-month period in 2014-2016. For monitored individuals, we identified unique durations of active monitoring that minimize expected costs for those at "low (but not zero) risk" and "some or high risk": 21 and 31 days, respectively. Extending our analysis to smallpox and MERS-CoV, we found that the optimal length of active monitoring relative to the median incubation period was reduced compared to Ebola due to less variable incubation periods. Active monitoring can save lives but is expensive. Resources can be most effectively allocated by using exposure-risk categories to modify the duration or intensity of active monitoring.

AB - During outbreaks of deadly emerging pathogens (e.g., Ebola, MERS-CoV) and bioterror threats (e.g., smallpox), actively monitoring potentially infected individuals aims to limit disease transmission and morbidity. Guidance issued by CDC on active monitoring was a cornerstone of its response to the West Africa Ebola outbreak. There are limited data on how to balance the costs and performance of this important public health activity. We present a framework that estimates the risks and costs of specific durations of active monitoring for pathogens of significant public health concern. We analyze data from New York City's Ebola active monitoring program over a 16-month period in 2014-2016. For monitored individuals, we identified unique durations of active monitoring that minimize expected costs for those at "low (but not zero) risk" and "some or high risk": 21 and 31 days, respectively. Extending our analysis to smallpox and MERS-CoV, we found that the optimal length of active monitoring relative to the median incubation period was reduced compared to Ebola due to less variable incubation periods. Active monitoring can save lives but is expensive. Resources can be most effectively allocated by using exposure-risk categories to modify the duration or intensity of active monitoring.

UR - http://www.scopus.com/inward/record.url?scp=85040822947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040822947&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-19406-x

DO - 10.1038/s41598-018-19406-x

M3 - Article

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 1093

ER -